24
NPS Score
VS
Alnylam Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 23
- TOTAL
RATINGS
Sorrento Therapeutics
- EMPLOYEE
PARTICIPANTS - 11
- TOTAL
RATINGS
Alnylam Pharmaceuticals vs Sorrento Therapeutics
Compare Alnylam Pharmaceuticals versus Sorrento Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 23 employees and customers of Alnylam Pharmaceuticals and 11 employees and customers of Sorrento Therapeutics.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Alnylam Pharmaceuticals. Their current market cap is $24.72B.
Sorrento Therapeutics
Sorrento Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Sorrento Therapeutics. Their current market cap is $145.01M.
3.8/5
Product Quality
1.5/5
3/5
Pricing
1.5/5
3.3/5
Customer Service
1.5/5
| 62% | Promoters |
|---|---|
| 0% | Passive |
| 38% | Detractors |
Net Promoter Score
Winner by 124
-100
NPS Score
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
See how Alnylam Pharmaceuticals compares to its competitors
See how Sorrento Therapeutics compares to its competitors
Working at Alnylam Pharmaceuticals vs Working at Sorrento Therapeutics
78 / 100
CEO Rating
Winner by 18%
60 / 100
CEO Rating
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Sorrento Therapeutics
Employees at Sorrento Therapeutics rate their CEO, Henry Ji, 60/100. This score is 18% lower than the scores of Alnylam Pharmaceuticals' CEO, John Maraganore.